|
1
|
Cao W, Chen HD, Yu YW, Li N and Chen WQ:
Changing profiles of cancer burden worldwide and in China: A
secondary analysis of the global cancer statistics 2020. Chin Med J
(Engl). 134:783–791. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Llovet JM, Kelley RK, Villanueva A, Singal
AG, Pikarsky E, Roayaie S, Lencioni R, Koike K, Zucman-Rossi J and
Finn RS: Hepatocellular carcinoma. Nat Rev Dis Primers. 7:62021.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Puisieux MF, Pellat A, Assaf A, Ginestet
C, Brezault C, Dhooge M, Soyer P and Coriat R: Therapeutic
management of advanced hepatocellular carcinoma: An updated review.
Cancers (Basel). 14:23572022. View Article : Google Scholar
|
|
4
|
Gao Y and Fang J: RNA 5-methylcytosine
modification and its emerging role as an epitranscriptomic mark.
RNA Biol. 18:117–127. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Cheng JX, Chen L, Li Y, Cloe A, Yue M, Wei
J, Watanabe KA, Shammo JM, Anastasi J, Shen QJ, et al: RNA cytosine
methylation and methyltransferases mediate chromatin organization
and 5-azacytidine response and resistance in leukaemia. Nat Commun.
9:1163. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Selmi T, Hussain S, Dietmann S, Heiß M,
Borland K, Flad S, Carter JM, Dennison R, Huang YL, Kellner S, et
al: Sequence- and structure-specific cytosine-5 mRNA methylation by
NSUN6. Nucleic Acids Res. 49:1006–1022. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Frye M, Harada BT, Behm M and He C: RNA
modifications modulate gene expression during development. Science.
361:1346–1349. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Janin M, Ortiz-Barahona V, de Moura MC,
Martínez-Cardús A, Llinàs-Arias P, Soler M, Nachmani D, Pelletier
J, Schumann U, Calleja-Cervantes ME, et al: Epigenetic loss of
RNA-methyltransferase NSUN5 in glioma targets ribosomes to drive a
stress adaptive translational program. Acta Neuropathol.
138:1053–1074. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Jiang Z, Li S, Han MJ, Hu GM and Cheng P:
High expression of NSUN5 promotes cell proliferation via cell cycle
regulation in colorectal cancer. Am J Transl Res. 12:3858–3870.
2020.PubMed/NCBI
|
|
10
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Hu L, Lau SH, Tzang CH, Wen JM, Wang W,
Xie D, Huang M, Wang Y, Wu MC, Huang JF, et al: Association of
Vimentin overexpression and hepatocellular carcinoma metastasis.
Oncogene. 23:298–302. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Tao QF, Yuan SX, Yang F, Yang Y, Yuan JH,
Wang ZG, Xu QG, Lin KY, Cai J, Yu J, et al: Aldolase B inhibits
metastasis through Ten-Eleven Translocation 1 and serves as a
prognostic biomarker in hepatocellular carcinoma. Mol Cancer.
14:1702015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Budwit-Novotny DA, McCarty KS, Cox EB,
Soper JT, Mutch DG, Creasman WT, Flowers JL and McCarty KS Jr:
Immunohistochemical analyses of estrogen receptor in endometrial
adenocarcinoma using a monoclonal antibody. Cancer Res.
46:5419–5425. 1986.PubMed/NCBI
|
|
14
|
Hou G, Chen L, Liu G, Li L, Yang Y, Yan
HX, Zhang HL, Tang J, Yang YC, Lin X, et al: Aldehyde
dehydrogenase-2 (ALDH2) opposes hepatocellular carcinoma
progression by regulating AMP-activated protein kinase signaling in
mice. Hepatology. 65:1628–1644. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Tandon N, Thakkar KN, LaGory EL, Liu Y and
Giaccia AJ: Generation of stable expression mammalian cell lines
using lentivirus. BIO Protoc. 8:e30732018. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Liu F, Yuan JH, Huang JF, Yang F, Wang TT,
Ma JZ, Zhang L, Zhou CC, Wang F, Yu J, et al: Long noncoding RNA
FTX inhibits hepatocellular carcinoma proliferation and metastasis
by binding MCM2 and miR-374a. Oncogene. 35:5422–5434. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Workman P, Aboagye EO, Balkwill F, Bruder
G, Chaplin DJ, Double JA, Everitt J, Farningham DAH, Glennie MJ,
Kelland LR, et al: Guidelines for the welfare and use of animals in
cancer research. Br J Cancer. 102:1555–1577. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Vasaikar SV, Straub P, Wang J and Zhang B:
LinkedOmics: Analyzing multi-omics data within and across 32 cancer
types. Nucleic Acids Res. 46:D956–D963. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Cancer Genome Atlas Research Network.
Electronic address, . simplewheeler@bcm.edu; Cancer
Genome Atlas Research Network: Comprehensive and integrative
genomic characterization of hepatocellular carcinoma. Cell.
169:1327–1341.e23. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Liao X and Zhang D: The 8th edition
american joint committee on cancer staging for
hepato-pancreato-biliary cancer: A review and update. Arch Pathol
Lab Med. 145:543–553. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Yu J, Xu QG, Wang ZG, Yang Y, Zhang L, Ma
JZ, Sun SH, Yang F and Zhou WP: Circular RNA cSMARCA5 inhibits
growth and metastasis in hepatocellular carcinoma. J Hepatol.
68:1214–1227. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Reig M, Forner A, Rimola J, Ferrer-Fàbrega
J, Burrel M, Garcia-Criado A, Kelley RK, Galle PR, Mazzaferro V,
Salem R, et al: BCLC strategy for prognosis prediction and
treatment recommendation: The 2022 update. J Hepatol. 76:681–693.
2022. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Nelson ME, Lahiri S, Chow JDY, Byrne FL,
Hargett SR, Breen DS, Olzomer EM, Wu LE, Cooney GJ, Turner N, et
al: Inhibition of hepatic lipogenesis enhances liver tumorigenesis
by increasing antioxidant defence and promoting cell survival. Nat
Commun. 8:14689. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Wilson CL, Mann DA and Borthwick LA:
Epigenetic reprogramming in liver fibrosis and cancer. Adv Drug
Deliv Rev. 121:124–132. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Thomas MB, Morris JS, Chadha R, Iwasaki M,
Kaur H, Lin E, Kaseb A, Glover K, Davila M and Abbruzzese J: Phase
II trial of the combination of bevacizumab and erlotinib in
patients who have advanced hepatocellular carcinoma. J Clin Oncol.
27:843–850. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Sun HC, Zhu XD, Huang C, Shen YH and Fan
J: Initially unresectable hepatocellular carcinoma treated by
combination therapy of tyrosine kinase inhibitor and anti-PD-1
antibody followed by resection. J Clin Oncol. 38:e16690. 2020.
View Article : Google Scholar
|
|
27
|
Heissenberger C, Liendl L, Nagelreiter F,
Gonskikh Y, Yang G, Stelzer EM, Krammer TL, Micutkova L, Vogt S,
Kreil DP, et al: Loss of the ribosomal RNA methyltransferase NSUN5
impairs global protein synthesis and normal growth. Nucleic Acids
Res. 47:11807–11825. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Chen P, Zhang T, Yuan Z, Shen B and Chen
L: Expression of the RNA methyltransferase Nsun5 is essential for
developing cerebral cortex. Mol Brain. 12:742019. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Yuan Z, Chen P, Zhang T, Shen B and Chen
L: Agenesis and hypomyelination of corpus callosum in mice lacking
Nsun5, an RNA methyltransferase. Cells. 8:5522019. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Hajiasgharzadeh K, Somi MH, Shanehbandi D,
Mokhtarzadeh A and Baradaran B: Small interfering RNA-mediated gene
suppression as a therapeutic intervention in hepatocellular
carcinoma. J Cell Physiol. 234:3263–3276. 2019. View Article : Google Scholar : PubMed/NCBI
|
